Vanda Pharmaceuticals (VNDA) Earnings Date, Estimates & Call Transcripts $4.19 +0.05 (+1.21%) Closing price 04/7/2025 04:00 PM EasternExtended Trading$4.24 +0.05 (+1.19%) As of 04/7/2025 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Vanda Pharmaceuticals Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 6After Market ClosesEstimatedActual EPS (Feb. 13) -$0.08 Beat By $0.06 Consensus EPS (Feb. 13) -$0.14 Vanda Pharmaceuticals posted Q4 2024 earnings on February 13, 2025, reporting an EPS of -$0.08, which topped the consensus estimate of -$0.14 by $0.06. Quarterly revenue was reported to be $53.19 million, above the consensus estimate of $51 million. With a trailing EPS of -$0.32, Vanda Pharmaceuticals' earnings are expected to grow next year, from ($1.12) to ($0.27) per share. Conference CallConference Call TranscriptVNDA Upcoming EarningsVanda Pharmaceuticals' next earnings date is estimated for Tuesday, May 6, 2025, based off prior year's reporting schedules. Get Vanda Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vanda Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataVNDA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VNDA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Vanda Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.52-$0.52-$0.52Q2 20251-$0.19-$0.19-$0.19Q3 20251-$0.11-$0.11-$0.11Q4 20251-$0.11-$0.11-$0.11FY 20254-$0.93-$0.93-$0.93Q1 20261-$0.08-$0.08-$0.08Q2 20261$0.06$0.06$0.06Q3 20261$0.10$0.10$0.10Q4 20261$0.14$0.14$0.14FY 20264$0.22$0.22$0.22 Remove Ads Vanda Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/6/2025(Estimated)-------2/13/2025Q4 2024-$0.14-$0.08+$0.06-$0.08$51.00M$53.19M7/31/2024Q2 2024--$0.08 -$0.08-$0.08-$50.47M5/8/2024Q1 2024$0.05-$0.07 -$0.12-$0.07$48.50M$47.46M2/7/2024Q4 2023-$0.09-$0.04+$0.05-$0.04$37.00M$45.27M7/27/2023Q2 2023-$0.13$0.03+$0.16$0.03$49.00M$46.06M5/3/2023Q1 2023-$0.06+$0.06$0.06-$62.50M Vanda Pharmaceuticals Earnings - Frequently Asked Questions When is Vanda Pharmaceuticals's earnings date? Vanda Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on VNDA's earnings history. What guidance has Vanda Pharmaceuticals issued on next quarter's earnings? Vanda Pharmaceuticals updated its FY 2025 earnings guidance on Thursday, February, 13th. The company issued revenue guidance of $210.0 million-$250.0 million, compared to the consensus revenue estimate of $284.9 million. Did Vanda Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Vanda Pharmaceuticals (NASDAQ:VNDA) reported ($0.08) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.14) by $0.06. Learn more on analysts' earnings estimate vs. VNDA's actual earnings. How can I listen to Vanda Pharmaceuticals's earnings conference call? The conference call for Vanda Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Vanda Pharmaceuticals's conference call transcript? The conference call transcript for Vanda Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Vanda Pharmaceuticals generate each year? Vanda Pharmaceuticals (NASDAQ:VNDA) has a recorded annual revenue of $198.77 million. How much profit does Vanda Pharmaceuticals generate each year? Vanda Pharmaceuticals (NASDAQ:VNDA) has a recorded net income of -$18.90 million. VNDA has generated -$0.32 earnings per share over the last four quarters. What is Vanda Pharmaceuticals's EPS forecast for next year? Vanda Pharmaceuticals's earnings are expected to grow from ($1.12) per share to ($0.27) per share in the next year. More Earnings Resources from MarketBeat Related Companies Novavax Earnings Geron Earnings Myriad Genetics Earnings Rigel Pharmaceuticals Earnings Verastem Earnings Emergent BioSolutions Earnings XOMA Earnings Ironwood Pharmaceuticals Earnings Codexis Earnings Sangamo Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Lamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go Higher Remove Ads This page (NASDAQ:VNDA) was last updated on 4/8/2025 by MarketBeat.com Staff From Our PartnersAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Hits $3,000… Here’s How You Can Get More for Under $20With gold surging to record highs, currently trading above $3,000 an ounce, and central banks aggressively sto...The Oxford Club | SponsoredDividend cuts are destroying retirements… is yours next?The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vanda Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vanda Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
